Uniformity Test Tablets Of Atorvastatin on the Market Using Ultraviolet Spectrophotometer

Sholichah Rohmani, Adi Yugatama, Ahmad Ainurofiq, Fea Prihapsara, Felicitas Lady

Abstract

Atorvastatin is one of the first choice in the treatment of dyslipidemia associated with a decreased risk of cardiovascular disease. Drug patent expires in 2011. Currently in Indonesia circulated atorvastatin dosage tablet innovator , several trade names , and one generic. The purpose of this study was conducted to determine the quality of the preparation of atorvastatin market in Indonesia through tablet dosage uniformity test , so that the appropriate levels of drugs can provide the desired therapeutic effect.Uniformity tablet dosage form of atorvastatin is done by measuring the uniformity of tablet weight, and content uniformity was done using ultraviolet spectrophotometry in methanol at the maximum wavelength of 246.2 nm and their validity was tested on the value of LOD (limit of detection), and LOQ (limit of quantitation). One- Way ANOVA analyzis was their also conducted.  The results showed that of the calculation data obtained , either in column A or column B that there is no deviation from the weight of the tablet , and based on the calculation of CV showed that all the tablets of atorvastatin in the market already qualified uniformity of weight as indicated by the value of CV < 5 %, and the levels atorvastatin tablet generic and tablets under the trade name meets the standard requirements of a tablet that in the range 90.0 % - 110.0 % of the amount listed on the label

Full Text:

PDF

References

Nováková, L., Vlčková, H., Šatínský, D., Sadílek, P., Solichová, D., Bláha, M., Bláha, V., and Solich P. Ultra High Performance Liquid Chromatography Tandem Mass Spectrometric Detection in Clinical Analysis of Simvastatin and Atorvastatin. J Chromatogr. 2009:877.

National Guideline Clearinghouse. American Association of Clinical Endocrinologists’ Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis. http://www.guideline.gov/content.aspx?id=37693. Published 2012.

Depkes RI. Farmakope Indonesia. V. Jakarta; 2014.

Kedokteran EGC. Pemastian Mutu Obat. I. Jakarta; 2005.

Kane PS. Bhokare DD. Simultaneous Spectrophotometric Estimation of Atorvastatin and Fenofibrate in Bulk Drug and Dosage Form by Using Dual Wavelength Method. Int J Res Pharm Biomed Sci. 2012;3(4):1448-1453.

Sawant Ramesh, Ahmed Raihan RS& DS. Spectrophotometric Methods For Simultaneous Estimation Of Atorvastatin And Niacin In Tablet Dosage Form. Int Res J Pharm. 2012;3(5):364-367.

Devi R R. New Spectrophotometric Methods For Simultaneous Determination Of Amlodipin Besylate And Atorvastatin Calcium In Tablet Dosage Form. Int Res J Pharm Pharm Sci. 2010;2(4):1322-1331.

Shrivastava, Alankar. GVB. Methods for the determination of limit of detection and limit of quantitation of the analytical methods. Rev Artic Dep Pharm Anal Madhya Pradesh India. 2011.

Aini, Nurul., Dian, Ratih., Sari IO. Profil Disolusi Terbanding, Penetapan Kadar, dan Kualitas Fisik Tablet Atorvastatin Inovator, Generik Bernama Dagang dan GenerikNo Title. J Kefarmasian Indones. 2015;5(2):90-97.

(AOAC) A of OAC. Guidelines for Standard Method Performance Requirements, Official Method of Analysis. Gaithersburg, Maryland, USA; 2012.

Chang Chung, C., Herman, L., & Lee CY., Z. X. (2004). Analitical Method Validation and Instrument Performance Verification. John Wiley & Sons, Inc. Publication.

Departemen Kesehatan, RI. (1995). Farmakope IndonesiaEdisi IV. Jakarta.

Moon, J. (2006). Switching Statins, BMJ : 1344-1345.

DOI: https://doi.org/10.20961/jpscr.v2i1.5234

Refbacks

  • There are currently no refbacks.